TECHNOLOGYSTAT NEWS
STAT+: AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs
Edison Scientific, a spin-off from AI scientist company FutureHouse, was created in late 2025 with $70 million in venture funding after pharmaceutical companies showed interest in their AI agents for drug discovery. FutureHouse, founded in 2023 by Sam Rodriques and Andrew White, initially aimed to scale scientific discovery through AI agents but pivoted to a commercial product due to demand from the pharmaceutical industry.
Mentioned
Related Signal
Adjacent reporting
- STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
- Exclusive: The researchers who built AI-generated DNA just raised $50 million to reinvent biology
- AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
- Eli Lilly deploys weight-loss cash on ‘App Store’ for scientists
- STAT+: An AI biotech CEO sets the record straight on AI drug development hype
- STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more